000			03755nam a22003975i 4500
999			_c8376 _d8376
001			8376
003			DE-He213
005			20201203160842.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			180605s2018 gw | s |||| 0|eng d
020			_a9783030518783
024	7		_a10.1007/978-3-030-51878-3 _2doi
040			_aES-MaUEC _bspa _dES-VaUE
050		4	_aRC645.73 _b.D53 2020 EB
245	1	0	_aDiagnosis and Management of Myelodysplastic Syndromes _bA Clinical Guide _cedited by Aziz Nazha
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2020
300			_a1 recurso en línea (VI-XII, 179 páginas) _bilustraciones a color
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aBiology, Pathophysiology, and Clinical Presentation of MDS Front Matter Pages 1-1 Epidemiology, Etiology, and Clinical Presentation of Myelodysplastic Syndromes Rena Buckstein Pages 3-17 Morphological, Flow Cytometry, and Cytogenetic Diagnosis of MDS Shalini Goel, Robert P. Hasserjian Pages 19-42 Biology and Pathophysiology of MDS with del(5q) Onyee Chan, Chetasi Talati, David Sallman, Alan List Pages 43-54 MDS Stem Cell Biology Matthew T. Villaume, P. Brent Ferrell, Michael R. Savona Pages 55-72 Molecular Landscape of MDS Torsten Haferlach, Ines Schmidts Pages 73-90 MDS Mimics Including CHIP, ICUS, and CCUS Rafael Bejar Pages 91-105 Prognosis Front Matter Pages 107-107 Prognostic Models in Myelodysplastic Syndromes Jan Philipp Bewersdorf, Amer M. Zeidan Pages 109-127 Treatment Front Matter Pages 129-129 Treatment Algorithms for Lower-Risk Myelodysplastic Syndrome Pierre Fenaux, Lionel Adès Pages 131-145 Treatment Algorithms for Higher-Risk Disease Bryan C. Hambley, Amy E. DeZern Pages 147-163 Hematopoietic Cell Transplantation for MDS Patients Anne Sophie Kubasch, Uwe Platzbecker Pages 165-173
520	3		_aMyelodysplastic syndromes (MDS) are a group of clonal disorders characterized by pancytopenias and the risk of progression to acute myeloid leukemia. The diagnosis of MDS can be challenging, while the outcomes of MDS patients vary widely. This book provides a concise yet comprehensive overview of MDS. The book begins by reviewing the diagnostic workup of MDS, with a specific focus on the 2016 WHO criteria for MDS diagnosis, and the biology and pathophysiology of the disease. The text then presents the molecular landscape of MDS and its impact on disease diagnosis, prognosis, and treatment decisions. The book continues by profiling different prognostic models of MDS and concludes with a thorough review of treatment algorithms for lower and higher-risk MDS, as well as the use of hematopoietic stem cell transplant to combat the disease. Written by experts in the field, Diagnosis and Management of Myelodysplastic Syndromes: A Clinical Guide is a valuable resource for clinicians, practitioners, and researchers who are interested in MDS. The text also features over 100 illustrations, photographs, and tables.
988			_aEBSPRINGER_2020
650		7	_9140122 _aHematología
650		7	_aOncología _9139207
650		7	_aMédula ósea
700			_aNazha, Aziz _9516038
710			_aSpringerLink _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9783030518776
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-51878-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db _feng _ggw _h0